این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
شنبه 25 بهمن 1404
International Journal of Hematology-Oncology and Stem Cell Research
، جلد ۱۹، شماره ۲، صفحات ۱۳۸-۱۵۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
High GVHD Prevalence in Travel-Based SCT despite Young Patients and HLA Matching
چکیده انگلیسی مقاله
Background: Patients from regions without stem cell transplantation (SCT) facilities often seek treatment abroad and return home for post-transplant care. Although extensive data exist on graft-versus-host disease (GVHD) and its risk factors, information on international SCT patients returning to countries that lack transplant facilities and expertise is scarce and not well documented. Materials and Methods: We screened 149 transplant recipients and analyzed the data of 91 patients who received transplants abroad and were followed up at our center from January 2019 to December 2022. This observational study used data from electronic medical records and employed descriptive statistics, inferential tests, and relative risk calculations with forest plots to analyze the prevalence of GVDH and its key risk factors. Results: Of the recipients, 31.8% were residents of nine countries residing in the UAE, and 67.2% were UAE citizens. Adults comprised 48.3% of the recipients, whereas 51.7% were pediatric patients. Hematological malignancy was the most common indication (49%), primarily in adults. Siblings comprised the majority of donors (52.6%), followed by related (23.09%) and unrelated donors (8.9%). Most patients (69.2%) received HLA-identical transplants, followed by 21.9% who received haplo-identical transplants. Among adults, 62.2% developed GVHD compared to 26% of pediatric patients. Recipients from related HLA-identical donors had a 50% prevalence of GVDH, whereas those from unrelated identical donors had a 71% prevalence. The overall prevalence of GVDH was 50% in 87.9% of patients who received allogeneic SCTs. Conclusion: Despite favorable factors, such as young age and matched related donors, we found a high prevalence of GVDH. Ocular GVHD was less prevalent than expected, and lung GVHD was weakly correlated with established risk factors. Larger multicenter studies are needed to assess and confirm the effect of contributing factors.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
| Naveed Syed
Department of Hematology-Oncology, Sheikh Shakbout Medical City, Abu Dhabi, UAE
| Imrana Afrooz
Department of Clinical Research, Sheikh Shakbout Medical City, Abu Dhabi, UAE
| Farooq Mir
Department of Hematology-Oncology, Sheikh Shakbout Medical City, Abu Dhabi, UAE
| Azmat Khan
Department of Hematology-Oncology, Sheikh Shakbout Medical City, Abu Dhabi, UAE
| Nada Abdulla
Mohammed Bin Rashid University of Medical Sciences, Dubai, UAE
| Shakir Hussain
1)Department of Hematopathology, Sheikh Shakbout Medical City, Abu Dhabi, UAE 2) Gulf Medical University, Ajman, UAE
| Ashok Chandani
Department of Hematology-Oncology, Sheikh Shakbout Medical City, Abu Dhabi, UAE
| Amera Hassan
University of Chicago, Chicago, USA
| Hanin Samad
Rashid Hospital, Dubai, UAE
| Gehad Ghazali
1) Sheikh Khalifa Medical City, :union:71, Pure Health, Abu Dhabi, UAE 2) College of Medicine and Health Sciences, Al Ain, UAE
| Shahrukh Hashmi
1) Mohammed Bin Zayed University of Artificial Intelligence, Abu Dhabi, UAE 2) Khalifa University, Abu Dhabi, UAE 3) Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA 4) Department of Health, Abu Dhabi, UAE
نشانی اینترنتی
https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/2168
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات